You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (34) |
Back to Search
Effectiveness of evolocumab in the treatment of familial hypercholesterolemia and cardiovascular disease
- At: Virtual 2020 (2020)
- Type: Poster
- Poster code: POS-PPM-006
- By: GARCÍA MARÍN, Javier (Hospital Punta de Europa, Farmacia, Spain)
- Co-author(s): Javier García Marín: Farmacia, Hospital Punta de Europa, ALGECIRAS, Spain
Marina Fages Pérez: Farmacia, Hospital Punta de Europa, ALGECIRAS, Spain
Alberto Soria Martín: Farmacia, Hospital Punta de Europa, ALGECIRAS, Spain
Javier Romero Puerto: Farmacia, Hospital Punta de Europa, ALGECIRAS, Spain
María Paz Quesada Sanz: Farmacia, Hospital Punta de Europa, ALGECIRAS, Spain
José Ramón Ávila Álvarez: Farmacia, Hospital Punta de Europa, ALGECIRAS, Spain - Abstract:
Background
Evolocumab is a monoclonal antibody that reduces LDL cholesterol (LDL-C) levels by binding to PCSK9.
Purpose
To evaluate the efficacy of evolocumab in the treatment of familial hypercholesterolemia (FH) and cardiovascular disease (CVD).
Methods
Observational and retrospective study of patients who started treatment with evolocumab
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026